Money

Found 79,340 articles

• Aligos Therapeutics Reports Recent Business Progress and First Quarter 2023 Financial Results

  5/4/2023

  Aligos Therapeutics, Inc. reported recent business progress and financial results for the first quarter 2023.

• Vaxart Provides Business Update and Reports First Quarter 2023 Financial Results  

  5/4/2023

  Vaxart, Inc. announced its business update and financial results for the first quarter of 2023.

• InfuSystem Reports First Quarter 2023 Financial Results

  5/4/2023

  InfuSystem Holdings, Inc., a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, reported financial results for the first quarter ended March 31, 2023.

• Cryoport Reports First Quarter 2023 Results

  5/4/2023

  Cryoport, Inc., a leading global provider of innovative temperature-controlled supply chain solutions for the life sciences, announced financial results for the three months ended March 31, 2023.

• Galapagos announces first quarter 2023 financial results

  5/4/2023

  Galapagos NV announced its first quarter 2023 financial results, a year-to-date business update and its outlook for the remainder of 2023.

• Assembly Biosciences Reports First Quarter 2023 Financial Results and Recent Highlights

  5/4/2023

  Assembly Biosciences, Inc., a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, reported financial results and recent highlights for the first quarter ended March 31, 2023.

• Karuna Therapeutics Reports First Quarter 2023 Financial Results and Provides General Business Updates

  5/4/2023

  Karuna Therapeutics, Inc. announced financial results for the first quarter of 2023 and provided a general business update.

• Onconova Therapeutics to Provide Corporate Update and Announce First Quarter 2023 Financial Results on May 15, 2023

  5/4/2023

  Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, announced that the Company intends to release its first quarter 2023 financial results on Monday, May 15, 2023.

• Codexis Reports First Quarter 2023 Financial Results

  5/4/2023

  Codexis, Inc., a leading enzyme engineering company, announced financial results for the first quarter ended March 31, 2023, and provided a business update.

• BD Reports Second Quarter Fiscal 2023 Financial Results

  5/4/2023

  BD, a leading global medical technology company, announced results for its second quarter of fiscal 2023, which ended March 31, 2023.

• Schrödinger Reports Strong First Quarter 2023 Financial Results

  5/4/2023

  Schrödinger, Inc., whose physics-based computational platform is transforming the way therapeutics and materials are discovered, announced financial results for the first quarter ended March 31, 2023.

• Relay Therapeutics Reports First Quarter 2023 Financial Results and Corporate Highlights

  5/4/2023

  Relay Therapeutics, Inc., a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, reported first quarter 2023 financial results and corporate highlights.

• Merus Announces Financial Results for the First Quarter 2023 and Provides Business Update

  5/4/2023

  Merus N.V., a clinical-stage oncology company developing innovative, full-length multispecific antibodies, announced financial results for the first quarter and provided a business update.

• Crinetics Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update

  5/4/2023

  Crinetics Pharmaceuticals, Inc. reported financial results for the first quarter ended March 31, 2023.

• Geron to Announce First Quarter 2023 Financial Results on May 11, 2023

  5/4/2023

  Geron Corporation, a late-stage clinical biopharmaceutical company, announced that it will release its first quarter 2023 financial results on Thursday, May 11, 2023 at 8:00 a.m. Eastern Time via press release, which will be available on the Company’s website.

• 4D Molecular Therapeutics Announces Proposed Public Offering of Common Stock - May 04, 2023

  5/4/2023

  4D Molecular Therapeutics, Inc., a clinical-stage biotherapeutics company harnessing the power of directed evolution for genetic medicines targeting large market diseases, announced that it has commenced an underwritten public offering of $100.0 million of shares of its common stock.

• Avalo Reports First Quarter 2023 Financial Results and Provides Business Updates

  5/4/2023

  Avalo Therapeutics, Inc., announced business updates and financial results for the first quarter of 2023.

• Eledon Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023

  5/4/2023

  Eledon Pharmaceuticals, Inc. announced that it plans to release financial results for the first quarter ended March 31, 2023 on Thursday, May 11, after the close of trading.

• 89bio Reports First Quarter 2023 Financial Results and Provides Corporate Update

  5/4/2023

  89bio, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, reported its financial results for the first quarter ended March 31, 2023.

• Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division

  5/4/2023

  Specialty cancer diagnostics company Precipio, Inc. announces another agreement with a new pathology services customer to utilize Precipio’s diagnostic services.